Trial Profile
Phase IIa study of imeglimin in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2012
Price :
$35
*
At a glance
- Drugs Imeglimin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Sep 2012 Results published in Diabetes, Obesity and Metabolism.
- 29 Aug 2012 New trial record